Pharmaceuticals, Biotechnology and Life Sciences
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it will report its …
Series C round led by RTW Investments, LP; RA Capital Management; Fidelity Management & Research Company; and funds and accounts advised by T. Rowe Price Associates, Inc.; and joined by existing investors including The Column Group, Casdin Capita…
Saama’s Smart Data Query, Smart Auto Mapper, Smart Programming Analytics & Computing Environment integrated into Oracle Health Sciences Clinical One platform.
Collaboration enables scale, agility, integrated user experience, and faster outcomes…
PALO ALTO, Calif.–(BUSINESS WIRE)–#biotech–Medable Inc., the leading cloud platform for patient-centered drug development, today announced a new partnership with Seqster to integrate real-time, real-world data streams into decentralized clinical tri…
DUBLIN–(BUSINESS WIRE)–The “Synovial Sarcoma – Market Insights, Epidemiology, and Market Forecast – 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering.
This report delivers an in-depth understanding of and historical and foreca…
DUBLIN–(BUSINESS WIRE)–The “Synovial Sarcoma – Market Insights, Epidemiology, and Market Forecast – 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering.
This report delivers an in-depth understanding of and historical and foreca…
DUBLIN–(BUSINESS WIRE)–The “Biologic Drug Product Contract Manufacturer Quality Benchmarking (4th Edition)” report has been added to ResearchAndMarkets.com’s offering.
This Biologic Drug Product Contract Manufacturing Quality Benchmarking report bri…
DUBLIN–(BUSINESS WIRE)–The “Biologic Drug Product Contract Manufacturer Quality Benchmarking (4th Edition)” report has been added to ResearchAndMarkets.com’s offering.
This Biologic Drug Product Contract Manufacturing Quality Benchmarking report bri…
LEEDS, England–(BUSINESS WIRE)–4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) – a novel class of drug derived from the microbiome, today announces the appointment of Paul Maier as No…
LEEDS, England–(BUSINESS WIRE)–4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) – a novel class of drug derived from the microbiome, today announces the appointment of Paul Maier as No…